On February 5, 2024, James Ahlers provided written notice to RenovoRx, Inc. (the ?Company?) of his resignation as the Company?s Chief Financial Officer, effective immediately. Mr. Ahlers resignation was for personal reasons and not as a result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | -6.16% | -5.52% | -40.17% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.17% | 32.81M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.47% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- RNXT Stock
- News RenovoRx, Inc.
- RenovoRx, Inc. Announces Resignation of James Ahlers as Chief Financial Officer